Cargando…
The power of comparative and developmental studies for mouse models of Down syndrome
Since the genetic basis for Down syndrome (DS) was described, understanding the causative relationship between genes at dosage imbalance and phenotypes associated with DS has been a principal goal of researchers studying trisomy 21 (Ts21). Though inferences to the gene-phenotype relationship in huma...
Autores principales: | Moore, Clara S., Roper, Randall J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer New York
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1998891/ https://www.ncbi.nlm.nih.gov/pubmed/17653795 http://dx.doi.org/10.1007/s00335-007-9030-8 |
Ejemplares similares
-
Understanding the Basis for Down Syndrome Phenotypes
por: Roper, Randall J, et al.
Publicado: (2006) -
Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models
por: Jamal, Raza, et al.
Publicado: (2022) -
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
por: Stringer, Megan, et al.
Publicado: (2017) -
Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts
por: Thomas, Jared R., et al.
Publicado: (2021) -
Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse
por: Dunlevy, Louisa, et al.
Publicado: (2010)